JP2005532986A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532986A5 JP2005532986A5 JP2003539658A JP2003539658A JP2005532986A5 JP 2005532986 A5 JP2005532986 A5 JP 2005532986A5 JP 2003539658 A JP2003539658 A JP 2003539658A JP 2003539658 A JP2003539658 A JP 2003539658A JP 2005532986 A5 JP2005532986 A5 JP 2005532986A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- water
- anticancer
- preparation
- butanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 9
- 238000002360 preparation method Methods 0.000 claims 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 8
- 230000001093 anti-cancer Effects 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 239000002842 anticancer formulation Substances 0.000 claims 5
- 239000000945 filler Substances 0.000 claims 5
- 238000009472 formulation Methods 0.000 claims 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 5
- 206010005003 Bladder cancer Diseases 0.000 claims 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 3
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 3
- 239000008101 lactose Substances 0.000 claims 3
- 201000005112 urinary bladder cancer Diseases 0.000 claims 3
- 238000000034 method Methods 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000012931 lyophilized formulation Substances 0.000 claims 1
- 238000012856 packing Methods 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34444601P | 2001-11-01 | 2001-11-01 | |
| PCT/US2002/035191 WO2003037314A2 (en) | 2001-11-01 | 2002-11-01 | Medical compositions for intravesical treatment of bladder cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005532986A JP2005532986A (ja) | 2005-11-04 |
| JP2005532986A5 true JP2005532986A5 (https=) | 2008-12-11 |
| JP4317452B2 JP4317452B2 (ja) | 2009-08-19 |
Family
ID=23350584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003539658A Expired - Lifetime JP4317452B2 (ja) | 2001-11-01 | 2002-11-01 | 膀胱癌の膀胱内処置用の医学的組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US6894071B2 (https=) |
| EP (3) | EP2060259B1 (https=) |
| JP (1) | JP4317452B2 (https=) |
| AT (2) | ATE493126T1 (https=) |
| AU (1) | AU2002350115A1 (https=) |
| CA (2) | CA2789114C (https=) |
| CY (1) | CY1111252T1 (https=) |
| DE (2) | DE60235214D1 (https=) |
| DK (2) | DK2060259T3 (https=) |
| ES (2) | ES2341922T3 (https=) |
| PT (2) | PT1864660E (https=) |
| WO (1) | WO2003037314A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE493126T1 (de) * | 2001-11-01 | 2011-01-15 | Spectrum Pharmaceuticals Inc | Medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs |
| US20080227841A1 (en) * | 2007-03-13 | 2008-09-18 | Luigi Lenaz | Intravesical apaziquone administration following transurethral resection |
| US8563592B2 (en) * | 2001-11-01 | 2013-10-22 | Spectrum Pharmaceuticals, Inc. | Bladder cancer treatment and methods |
| US8361490B2 (en) | 2004-09-16 | 2013-01-29 | Theracoat Ltd. | Biocompatible drug delivery apparatus and methods |
| AU2006230582A1 (en) * | 2005-03-31 | 2006-10-05 | Spectrum Pharmaceuticals, Inc. | Indoloquinone tumor radiation sensitization |
| CA2653541C (en) | 2005-06-06 | 2014-12-23 | The University Of British Columbia | Polymer-based serum albumin substitute |
| JP2009526085A (ja) * | 2006-02-09 | 2009-07-16 | スペクトラム ファーマシューティカルズ インコーポレイテッド | Eo9およびプロピレングリコールの使用による膀胱癌の治療 |
| US20080114021A1 (en) * | 2006-11-09 | 2008-05-15 | University Of Maryland Baltimore | Use Of 5,6-Dimethylxanthenone-4-Acetic Acid as an Antimicrobial Agent |
| RU2354386C1 (ru) * | 2007-12-26 | 2009-05-10 | ГУ Московская городская онкологическая больница №62 Департамента здравоохранения г. Москвы | Способ профилактики рецидивов поверхностного рака мочевого пузыря |
| GB0800311D0 (en) * | 2008-01-09 | 2008-02-20 | Cytosystems Ltd | Apparatus and method for filtering biological material |
| ES2732150T3 (es) | 2010-01-20 | 2019-11-20 | Urogen Pharma Ltd | Material y método para tratar cavidades internas |
| CN102906157B (zh) | 2010-03-01 | 2016-08-24 | 不列颠哥伦比亚大学 | 衍生的超支化聚丙三醇 |
| PT2619331T (pt) * | 2010-09-22 | 2018-06-01 | Univ Texas | Métodos de tratamento de cancro incluindo rastreio de nqo1 |
| EP2734187B1 (en) | 2011-07-20 | 2018-09-05 | UroGen Pharma Ltd. | Materials and method for treating internal body cavities |
| HUE032240T2 (en) | 2011-10-24 | 2017-09-28 | Asana Biosciences Llc | cyclohexylamines |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| JP6616772B2 (ja) | 2013-12-16 | 2019-12-04 | アサナ・バイオサイエンシズ,リミテッド・ライアビリティ・カンパニー | P2x3および/またはp2x2/3化合物ならびに方法 |
| CN104743887B (zh) * | 2014-09-22 | 2016-03-23 | 巨石集团有限公司 | 一种玻璃纤维组合物及其玻璃纤维和复合材料 |
| CN109996546B (zh) | 2016-09-30 | 2023-06-27 | 阿沙纳生物科学公司 | P2x3和/或p2x2/3化合物及方法 |
| WO2020168244A1 (en) | 2019-02-15 | 2020-08-20 | Incelldx, Inc. | Assaying bladder-associated samples, identifying and treating bladder-associated neoplasia, and kits for use therein |
| CN112220742A (zh) * | 2019-07-15 | 2021-01-15 | 深圳艾欣达伟医药科技有限公司 | 稳定的ast-3424注射液制剂及制备方法 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3993754A (en) * | 1974-10-09 | 1976-11-23 | The United States Of America As Represented By The United States Energy Research And Development Administration | Liposome-encapsulated actinomycin for cancer chemotherapy |
| JPS54151134A (en) | 1978-05-19 | 1979-11-28 | Kureha Chem Ind Co Ltd | Antitumorigenic agent |
| NL8001280A (nl) * | 1980-03-04 | 1981-10-01 | Philips Nv | Lagedrukontladingslamp. |
| AU565354B2 (en) | 1983-11-14 | 1987-09-10 | Bio-Mimetics Inc. | Bioadhesive compositions and methods of treatment therewith |
| US4898729A (en) | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| US4671954A (en) * | 1983-12-13 | 1987-06-09 | University Of Florida | Microspheres for incorporation of therapeutic substances and methods of preparation thereof |
| JPS60163621A (ja) | 1984-02-02 | 1985-08-26 | 村上 俊文 | 紙製便座カバ−の製造方法 |
| JPS60163821A (ja) | 1984-02-03 | 1985-08-26 | Tdk Corp | フエライト粒子を含む薬剤用担体 |
| JPS61189215A (ja) | 1985-02-18 | 1986-08-22 | Teijin Ltd | 5−フルオロ−2′−デオキシウリジンエステル類の油状医薬組成物 |
| WO1987006227A2 (en) * | 1986-04-17 | 1987-10-22 | Jouhar Akbar Jan | Indoloquinone compounds |
| US4871542A (en) * | 1987-04-30 | 1989-10-03 | Ferring Service Center, N.V. | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract |
| EP0331635A3 (en) | 1988-02-29 | 1990-02-28 | The Board of Regents of the University of Texas System | Preparations for treating bladder cancer |
| EP0338679A3 (en) | 1988-03-24 | 1991-03-06 | Genentech, Inc. | Tumour necrosis factor in the treatment of bladder cancer |
| FR2629584B1 (fr) | 1988-03-31 | 1993-06-04 | France Etat Armement | Dispositif de stabilisation pour un projectile a faible moment d'inertie longitudinal tire a partir d'un tube raye |
| US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
| US5744166A (en) * | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
| PT93772A (pt) * | 1989-04-17 | 1991-01-08 | Searle & Co | Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer |
| US5216011A (en) * | 1989-09-01 | 1993-06-01 | Bristol-Myers Squibb Co. | Stable solutions of mitomycin c |
| US5237466A (en) | 1989-11-02 | 1993-08-17 | International Business Machines Corporation | Method and apparatus for programmably controlling spindle synchronization and phase among disk drives in a storage subsystem |
| FI84874C (fi) | 1989-11-02 | 1992-02-10 | Valio Meijerien | Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den. |
| US5292516A (en) * | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
| US5346703A (en) * | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| IT1250421B (it) | 1991-05-30 | 1995-04-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive. |
| US5550110A (en) | 1992-04-22 | 1996-08-27 | Warner-Lambert Company | Endothelin Antagonists II |
| JP3598049B2 (ja) | 1992-09-18 | 2004-12-08 | 山之内製薬株式会社 | ハイドロゲル徐放性製剤 |
| US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
| EP0995447A1 (en) | 1993-09-09 | 2000-04-26 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
| CA2135151A1 (en) | 1993-11-08 | 1995-05-09 | Mitsuhiro Wakimasu | Cyclic hexapeptides, their production and use |
| US5405622A (en) * | 1993-12-22 | 1995-04-11 | Vernice; Joseph | Gamma radiation resistant lubricating gel |
| TW438601B (en) * | 1994-05-18 | 2001-06-07 | Janssen Pharmaceutica Nv | New mucoadhesive emulsion compositions and a process for the preparation thereof |
| US5811416A (en) | 1994-06-06 | 1998-09-22 | Board Of Regents The University Of Texas System | Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate |
| US5612359A (en) | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
| EP2301562B1 (en) | 1994-12-12 | 2013-04-17 | Omeros Corporation | Irrigation solution and method for inhibition of pain, inflammation and spasm |
| US5749845A (en) * | 1995-01-25 | 1998-05-12 | Iotek, Inc. | Delivering an agent to an organ |
| WO1997023456A1 (en) | 1995-12-21 | 1997-07-03 | British Technology Group Ltd. | Indoloquinone derivatives as bioreductive agents |
| US5985312A (en) * | 1996-01-26 | 1999-11-16 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers |
| JP2000509014A (ja) * | 1996-03-11 | 2000-07-18 | フォーカル,インコーポレイテッド | 放射性核種および放射性医薬品のポリマー送達 |
| US5955096A (en) * | 1996-06-25 | 1999-09-21 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients |
| US6251861B1 (en) | 1996-06-27 | 2001-06-26 | Takeda Chemical Industries, Ltd. | Treatment of cerebral infarction using cyclic hexapeptides |
| JP2967734B2 (ja) * | 1996-10-18 | 1999-10-25 | 日本電気株式会社 | 薄膜の形成方法 |
| EP0971641A4 (en) * | 1997-04-03 | 2003-08-13 | Point Biomedical Corp | SYSTEM FOR THE ADMINISTRATION OF AN INTRAVESICAL MEDICINAL PRODUCT |
| US5854382A (en) * | 1997-08-18 | 1998-12-29 | Meadox Medicals, Inc. | Bioresorbable compositions for implantable prostheses |
| AU9082698A (en) * | 1997-09-08 | 1999-03-29 | Theramark Limited | Treatment of inflammatory conditions |
| US6156744A (en) | 1998-03-19 | 2000-12-05 | Cancer Research Campaign Tech (London) | DT-diaphorase directed anti-tumor agents |
| EP0950418A2 (en) | 1998-04-14 | 1999-10-20 | Takeda Chemical Industries, Ltd. | Composition for preventing or treating ischemic disease |
| US6171610B1 (en) * | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
| KR20010043322A (ko) | 1998-05-05 | 2001-05-25 | 아스트라제네카 악티에볼라그 | 미코박테리아성 억제제 |
| IL124957A0 (en) | 1998-06-16 | 1999-01-26 | Univ Ben Gurion | Active ingredient delivery systems and devices based on porous matrices |
| US6087396A (en) * | 1998-10-05 | 2000-07-11 | Situs Corporation | Oxybutynin formulations and method of use |
| GB9827034D0 (en) | 1998-12-10 | 1999-02-03 | Univ Manchester | Delivery formulation |
| JP2000256182A (ja) | 1999-03-03 | 2000-09-19 | Kazuhiro Morimoto | 抗菌製剤 |
| WO2000067023A1 (en) | 1999-04-29 | 2000-11-09 | Coley Pharmaceutical Gmbh | Screening for immunostimulatory dna functional modifyers |
| US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
| US6545048B1 (en) | 1999-06-29 | 2003-04-08 | California Institute Of Technology | Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity |
| WO2001091736A2 (en) | 2000-05-31 | 2001-12-06 | Warner-Lambert Company | Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| MXPA03004832A (es) | 2000-12-01 | 2004-05-04 | Guilford Pharm Inc | Compuestos y sus usos. |
| WO2002049630A2 (en) | 2000-12-21 | 2002-06-27 | Bristol-Myers Squibb Company | Method for preventing or treating pain by administering an endothelin antagonist |
| WO2003009805A2 (en) | 2001-07-23 | 2003-02-06 | Brigham And Women's Hospital, Inc. | Analgesic methods using endothelin receptor ligands |
| ATE493126T1 (de) | 2001-11-01 | 2011-01-15 | Spectrum Pharmaceuticals Inc | Medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs |
| US7973064B2 (en) | 2001-11-27 | 2011-07-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for potentiating an opiate analgesic |
| JP5184738B2 (ja) | 2002-05-03 | 2013-04-17 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 修飾第vii因子の安定化された固体組成物 |
| US20040009918A1 (en) | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
| JP2006508086A (ja) | 2002-10-24 | 2006-03-09 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ | 固形腫瘍を予防および治療するための方法および組成物 |
| HRP20140338T1 (hr) | 2005-07-25 | 2014-06-20 | Emergent Product Development Seattle, Llc | Smanjenje broja b-stanica upotrebom molekula koje se specifiäśno vežu na cd37 i cd20 |
| JP2009526085A (ja) | 2006-02-09 | 2009-07-16 | スペクトラム ファーマシューティカルズ インコーポレイテッド | Eo9およびプロピレングリコールの使用による膀胱癌の治療 |
-
2002
- 2002-11-01 AT AT06077149T patent/ATE493126T1/de active
- 2002-11-01 PT PT06077149T patent/PT1864660E/pt unknown
- 2002-11-01 DK DK09075067.0T patent/DK2060259T3/da active
- 2002-11-01 DE DE60235214T patent/DE60235214D1/de not_active Expired - Lifetime
- 2002-11-01 US US10/285,783 patent/US6894071B2/en not_active Expired - Lifetime
- 2002-11-01 CA CA2789114A patent/CA2789114C/en not_active Expired - Fee Related
- 2002-11-01 ES ES09075067T patent/ES2341922T3/es not_active Expired - Lifetime
- 2002-11-01 AT AT09075067T patent/ATE455545T1/de active
- 2002-11-01 AU AU2002350115A patent/AU2002350115A1/en not_active Abandoned
- 2002-11-01 ES ES06077149T patent/ES2384208T3/es not_active Expired - Lifetime
- 2002-11-01 WO PCT/US2002/035191 patent/WO2003037314A2/en not_active Ceased
- 2002-11-01 CA CA2466148A patent/CA2466148C/en not_active Expired - Fee Related
- 2002-11-01 EP EP09075067A patent/EP2060259B1/en not_active Expired - Lifetime
- 2002-11-01 DE DE60238798T patent/DE60238798D1/de not_active Expired - Lifetime
- 2002-11-01 PT PT09075067T patent/PT2060259E/pt unknown
- 2002-11-01 EP EP02786643A patent/EP1439835A2/en not_active Withdrawn
- 2002-11-01 JP JP2003539658A patent/JP4317452B2/ja not_active Expired - Lifetime
- 2002-11-01 EP EP06077149A patent/EP1864660B1/en not_active Expired - Lifetime
- 2002-11-01 DK DK06077149.0T patent/DK1864660T3/da active
-
2005
- 2005-04-01 US US11/096,566 patent/US20050215615A1/en not_active Abandoned
-
2006
- 2006-09-13 US US11/531,535 patent/US20070010570A1/en not_active Abandoned
-
2008
- 2008-03-21 US US12/053,418 patent/US7977369B2/en not_active Expired - Fee Related
- 2008-12-03 US US12/327,781 patent/US20090076123A1/en not_active Abandoned
-
2011
- 2011-02-14 CY CY20111100183T patent/CY1111252T1/el unknown
-
2012
- 2012-06-11 US US13/493,911 patent/US8648108B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005532986A5 (https=) | ||
| CN1125653C (zh) | 含有伏利康唑的药物制剂 | |
| JP3529142B2 (ja) | シクロデキストリンを含むガレヌス製剤 | |
| JP2002518318A5 (https=) | ||
| CN1826117A (zh) | 口腔溶解薄膜 | |
| JP2002363097A5 (https=) | ||
| JP2001522783A5 (https=) | ||
| NZ237583A (en) | Preparation of piroxicam - cyclodextrin complexes and pharmaceutical compositions thereof | |
| US6403083B1 (en) | Interleukin-12 inducer and medical composition | |
| JP2004067682A (ja) | 抗生物質活性を有する薬学的組成物 | |
| Marshall et al. | Galactosylated streptavidin for improved clearance of biotinylated intact and F (ab') 2 fragments of an anti-tumour antibody | |
| EP1129709B1 (en) | Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof | |
| GB2153225A (en) | Effervescent preparations containing diphosphonates | |
| JPH0310608B2 (https=) | ||
| HUP0900614A2 (en) | Preparation comprising dehydrated, fermented material with amorphous crystaline structure and process for its production | |
| CN101141952B (zh) | 新的软胶囊 | |
| JP4395368B2 (ja) | 細胞殺傷活性を有するカルシウム塩 | |
| KR100834148B1 (ko) | 이트라코나졸을 유효성분으로 하는 약학적 조성물 | |
| JP2005528351A5 (https=) | ||
| JP6125634B2 (ja) | 薬用粘土製剤 | |
| JP3294033B2 (ja) | オブラート | |
| JP5977672B2 (ja) | イブプロフェンリシナートの経口投与用の懸濁液 | |
| JP2001081047A5 (https=) | ||
| JPH0378368B2 (https=) | ||
| JP3568957B2 (ja) | 改善された医薬特性を示すエストラムスチン処方物 |